Biosketch / Results /
Melanie B. Shulman, M.D.
Clinical Assistant Professor; Assoc Dir Cognitive & Behavioral Nrlgy-Barlow CtrDepartments of Neurology and Psychiatry (Barlow Center)
NYU Pearl Barlow Center for Memory Evaluation and Treatment
Clinical Addresses
145 EAST 32ND STREET2ND FLOOR
NEW YORK, NY 10016
Hours: Tue. 9 - 12; Thu. 9 - 5; Fri. 9 - 5
Handicap Access: yes
Phone: 212-263-3210
Fax: 212-263-3273
Medical Specialties
NeurologyMedical Expertise
Alzheimer's Disease, Memory Disorders, Cerebrovascular Disease, Trauma, Language/Cognition Adult, Behavioral Neurology/Neuropsyc, Women's NeurologyInsurance
AETNA HMO, AETNA MEDICARE, AETNA PPO, Cigna HMO/POS, Cigna PPO, EBCBS CHLD HLTH, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, NYS EMPIRE PLAN, OXFORD FREEDOM, Oxford Medicare, UHC EPO, UHC HMO, UHC POS, UHC PPO, UHC TOP TIERInsurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.
Board Certification
1999 — NeurologyEducation
1987-1991 — Univ. of Pennsylvania School of Medicine, Medical Education1991-1992 — Mount Auburn Hospital, Internship
1992-1995 — Brigham and Women's Hospital (Neurology), Residency Training
1995-1996 — Braintree Hospital (Behavioral Neurology), Clinical Fellowships
All data from NYU Health Sciences Library Faculty Bibliography — -
Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search#about
Methodologies for Clinical Trials in Pre-MCI Persons with Subjective Cognitive Impairment
Reisberg, B; Shulman, MB; Osorio, RS; Kumar, P; Gill, TJ; Janisar, M; Lobach, I
26th International Conference of Alzheimer's Disease International Bologna : MEDIMOND s.r.l., 2011,
—
id: 5772,
year: 2011,
vol: ,
page: 81,
stat: Chapter,
Clinical Assessment Methodology for Alzheimer's Disease Prevention Trials: A Global and Multi-Axial 2 Year Study of Pre-Mild Cognitive Impairment (Pre-MCI) Subjective Cognitive Impairment (SCI)
Reisberg, Barry; Osorio, Ricardo; Khan, Asif; Roy, Kamalika; Torossian, Carol; Monteiro, Isabel; Anwar, Salman; Shulman, Melanie B; Lobach, Iryna
2011 ;36:?-? #70, Neuropsychopharmacology
—
id: 147669,
year: 2011,
vol: 36,
page: ?,
stat: Journal Article,
Outcome over seven years of healthy adults with and without subjective cognitive impairment
Reisberg, Barry; Shulman, Melanie B; Torossian, Carol; Leng, Ling; Zhu, Wei
2010 Jan;6(1):11-24, Alzheimer's & Dementia
BACKGROUND: Subjective cognitive impairment (SCI) in older persons without manifest symptomatology is a common condition with a largely unclear prognosis. We hypothesized that (1) examining outcome for a sufficient period by using conversion to mild cognitive impairment (MCI) or dementia would clarify SCI prognosis, and (2) with the aforementioned procedures, the prognosis of SCI subjects would differ significantly from that of demographically matched healthy subjects, free of SCI, termed no cognitive impairment (NCI) subjects. METHODS: A consecutive series of healthy subjects, aged > or =40 years, presenting with NCI or SCI to a brain aging and dementia research center during a 14-year interval, were studied and followed up during an 18-year observation window. The study population (60 NCI, 200 SCI, 60% female) had a mean age of 67.2 +/- 9.1 years, was well-educated (mean, 15.5 +/- 2.7 years), and cognitively normal (Mini-Mental State Examination, 29.1 +/- 1.2). RESULTS: A total of 213 subjects (81.9% of the study population) were followed up. Follow-up occurred during a mean period of 6.8 +/- 3.4 years, and subjects had a mean of 2.9 +/- 1.6 follow-up visits. Seven NCI (14.9%) and 90 SCI (54.2%) subjects declined (P < .0001). Of NCI decliners, five declined to MCI and two to probable Alzheimer's disease. Of SCI decliners, 71 declined to MCI and 19 to dementia diagnoses. Controlling for baseline demographic variables and follow-up time, Weibull proportional hazards model revealed increased decline in SCI subjects (hazard ratio, 4.5; 95% confidence interval, 1.9-10.3), whereas the accelerated failure time model analysis with an underlying Weibull survival function showed that SCI subjects declined more rapidly, at 60% of the rate of NCI subjects (95% confidence interval, 0.45-0.80). Furthermore, mean time to decline was 3.5 years longer for NCI than for SCI subjects (P = .0003). CONCLUSIONS: These results indicate that SCI in subjects with normal cognition is a harbinger of further decline in most subjects during a 7-year mean follow-up interval. Relevance for community populations should be investigated, and prevention studies in this at-risk population should be explored
—
id: 107277,
year: 2010,
vol: 6,
page: 11,
stat: Journal Article,
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import
Reisberg, Barry; Shulman, Melanie B
2009 Mar;5(2):154-156, Alzheimer's & Dementia
—
id: 100593,
year: 2009,
vol: 5,
page: 154,
stat: Journal Article,
Steroid dementia: A follow-up
Sacks, O; Shulman, M
2007 FEB 20 ;68(8):622-622, Neurology
—
id: 71003,
year: 2007,
vol: 68,
page: 622,
stat: Journal Article,
Steroid dementia: An overlooked diagnosis?
Sacks, O; Shulman, M
2005 FEB 22 ;64(4):707-709, Neurology
The authors studied a 72-year-old man with polymyalgia rheumatica who, after taking 100 mg of prednisone for 3 months, developed a psychosis followed by dementia. It was initially considered that the dementia was a separate neurodegenerative condition, probably of Alzheimer type, but when steroids were discontinued, he rapidly returned to his previous level of functioning. Reviewing the literature regarding the effects of steroids on cerebral function, the authors found that such cases of 'reversible dementia' are not uncommon, although rarely given the emphasis they deserve. The authors believe, given the extensive use of steroids in medical practice, that physicians should be more aware of this important cause of reversible dementia
—
id: 48916,
year: 2005,
vol: 64,
page: 707,
stat: Journal Article,
Laterality and psychopathology circa 1976
Shulman, Melanie B
2003 Oct;4(5):576-577, Epilepsy & behavior
—
id: 42655,
year: 2003,
vol: 4,
page: 576,
stat: Journal Article,
The clinical applications of EEG: origins
Shulman MB
2002 Aug;3(4):393-394, Epilepsy & behavior
—
id: 39288,
year: 2002,
vol: 3,
page: 393,
stat: Journal Article,
Treatment of memory disorders in epilepsy
Shulman MB; Barr W
2002 Oct;3(5S):30-34, Epilepsy & behavior
Impaired memory is a common and often debilitating complaint in patients with epilepsy. Overlapping variables such as seizure control, attentional dysfunction, and mood disorders further complicate diagnosis and management. Direct therapy for memory deficits associated with epilepsy is rarely attempted. The varied pharmacological (AED selection, cholinesterase inhibitors, stimulants, antidepressants, and herbal supplements) and nonpharmacological approaches to cognitive remediation in epilepsy patients are reviewed
—
id: 95532,
year: 2002,
vol: 3,
page: 30,
stat: Journal Article,
Triangular backgrounds shift the bias of line bisection performance in hemispatial neglect
Shulman, M B; Alexander, M P; McGlinchey-Berroth, R; Milberg, W
2002 Jan;72(1):68-72, Journal of neurology neurosurgery & psychiatry
OBJECTIVE: Patients with left neglect on line bisection show normal implicit sensitivity to manipulations of both the stimulus and the visual background. Three experiments were designed to define this sensitivity more exactly. METHODS: Normal controls and patients with left neglect performed a series of horizontal line bisection tasks. Independent variables were the configurations of the backgrounds for the line-rectangle, square, circle, left and right pointing isosceles triangles-and whether the background was the shape of the piece of paper or an outline drawn on a standard piece of paper. In a separate experiment different components of the triangle were outlined on a piece of paper. Deviation from true midpoint was calculated. RESULTS: Simply placing the target lines in a symmetric background such as a square or circle did not reliably reduce neglect. A triangle asymmetric in the horizontal plane caused a shift in bisection away from the triangle's vertex. With right pointing triangles the perceived midpoint shifted to the left of true centre (crossed over). The effects of the triangles were comparable in the patients and the controls when controlled for baseline bisection bias. The critical components of the triangles were the angular legs. This effect of background was not influenced by lesion site or by hemianopia. CONCLUSIONS: Patients with left visual neglect remain sensitive to covert manipulations of the visual background that implicitly shift the perceived midpoint of a horizontal line. This effect is strong enough to eliminate neglect on a bisection task. The mechanism of this effect is expressed through preattentive visual capacities
—
id: 26512,
year: 2002,
vol: 72,
page: 68,
stat: Journal Article,
The Frontal Lobes, Epilepsy, and Behavior
Shulman MB
2000 Dec;1(6):384-395, Epilepsy & behavior
The frontal lobes have been overshadowed by the temporal lobes in the vast literature addressing the neurobehavioral and psychological perspectives of epilepsy. The purpose of this review is to summarize contemporary anatomicobehavioral correlations and to highlight the frontal lobe contributions to the neurology, neuropsychology, and neuropsychiatry of epilepsy, in general, and to temporal lobe epilepsy (TLE) and frontal lobe epilepsy (FLE), in particular. Much evidence has accumulated suggesting that focal epileptogenic tissue may have effects on distant neural systems. Data supporting the case that the frontal regions are preferentially affected in TLE are presented. Emphasis is placed on the results of numerous functional imaging studies demonstrating correlations between frontal hypoperfusion and cognitive or mood impairments in patients with TLE
—
id: 63728,
year: 2000,
vol: 1,
page: 384,
stat: Journal Article,


